Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer
- 1 March 2004
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 92 (3) , 927-935
- https://doi.org/10.1016/j.ygyno.2003.11.055
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Cyclooxygenase-2 (COX-2), Epidermal Growth Factor Receptor (EGFR), and Her-2/neu Expression in Ovarian CancerGynecologic Oncology, 2002
- The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancerZeitschrift für Krebsforschung und Klinische Onkologie, 2002
- Expression of Cyclooxygenase 2 Is an Independent Prognostic Factor in Human Ovarian CarcinomaThe American Journal of Pathology, 2002
- Survival among U.S. Women with Invasive Epithelial Ovarian CancerGynecologic Oncology, 2002
- Vascular Endothelial Growth Factor Expression in Serous Ovarian Carcinoma: Relationship with High Mitotic Activity and High FIGO StageGynecologic Oncology, 2002
- High Cyclooxygenase-2 Expression in Stage IB Cervical Cancer with Lymph Node Metastasis or Parametrial InvasionGynecologic Oncology, 2000
- Prognostic Significance of p53 and p21waf1/cip1 Immunoreactivity in Epithelial Cancers of the OvaryGynecologic Oncology, 1999
- Expression and localization of cyclo-oxygenase isoforms in non-small cell lung cancerEuropean Respiratory Journal, 1999
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- Role of oxygen free radicals in cancer developmentEuropean Journal Of Cancer, 1996